These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26662991)

  • 1. microRNA and NF-kappa B.
    Yuan Y; Tong L; Wu S
    Adv Exp Med Biol; 2015; 887():157-70. PubMed ID: 26662991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncoding RNAs Regulating NF-κB Signaling.
    Li M; Guan H
    Adv Exp Med Biol; 2016; 927():317-36. PubMed ID: 27376741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-κB target microRNAs and their target genes in TNFα-stimulated HeLa cells.
    Zhou F; Wang W; Xing Y; Wang T; Xu X; Wang J
    Biochim Biophys Acta; 2014; 1839(4):344-54. PubMed ID: 24418602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic microRNAs targeting the NF-kappa B signaling circuits of cancers.
    Tong L; Yuan Y; Wu S
    Adv Drug Deliv Rev; 2015 Jan; 81():1-15. PubMed ID: 25220353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA Roles in the Nuclear Factor Kappa B Signaling Pathway in Cancer.
    Wu J; Ding J; Yang J; Guo X; Zheng Y
    Front Immunol; 2018; 9():546. PubMed ID: 29616037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
    Mirzaei S; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Ranjbar A; Seyed Saleh SH; Bagherian M; Sharifzadeh SO; Hushmandi K; Liskova A; Kubatka P; Makvandi P; Tergaonkar V; Kumar AP; Ashrafizadeh M; Sethi G
    Cancer Lett; 2021 Jul; 509():63-80. PubMed ID: 33838282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-30c-2-3p negatively regulates NF-κB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer.
    Shukla K; Sharma AK; Ward A; Will R; Hielscher T; Balwierz A; Breunig C; Münstermann E; König R; Keklikoglou I; Wiemann S
    Mol Oncol; 2015 Jun; 9(6):1106-19. PubMed ID: 25732226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α.
    Bao C; Li Y; Huan L; Zhang Y; Zhao F; Wang Q; Liang L; Ding J; Liu L; Chen T; Li J; Yao M; Huang S; He X
    Sci Signal; 2015 Jul; 8(387):ra75. PubMed ID: 26221053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-22 and microRNA-140 suppress NF-κB activity by regulating the expression of NF-κB coactivators.
    Takata A; Otsuka M; Kojima K; Yoshikawa T; Kishikawa T; Yoshida H; Koike K
    Biochem Biophys Res Commun; 2011 Aug; 411(4):826-31. PubMed ID: 21798241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a.
    Pacifico F; Crescenzi E; Mellone S; Iannetti A; Porrino N; Liguoro D; Moscato F; Grieco M; Formisano S; Leonardi A
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1421-30. PubMed ID: 20061417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-21 and let-7 in the Ras and NF-κB pathways.
    Choudhury SN; Li Y
    Microrna; 2012; 1(1):65-9. PubMed ID: 25048092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase alpha and TAB3 in hepatocellular carcinoma.
    Ding J; Huang S; Wang Y; Tian Q; Zha R; Shi H; Wang Q; Ge C; Chen T; Zhao Y; Liang L; Li J; He X
    Hepatology; 2013 Aug; 58(2):654-66. PubMed ID: 23487264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA analysis suggests an additional level of feedback regulation in the NF-κB signaling cascade.
    Mechtler P; Singhal R; Kichina JV; Bard JE; Buck MJ; Kandel ES
    Oncotarget; 2015 Jul; 6(19):17097-106. PubMed ID: 26020802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pax-5 Inhibits NF-κB Activity in Breast Cancer Cells Through IKKε and miRNA-155 Effectors.
    Harquail J; LeBlanc N; Landry C; Crapoulet N; Robichaud GA
    J Mammary Gland Biol Neoplasia; 2018 Sep; 23(3):177-187. PubMed ID: 30032344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction between miRNAs/lncRNAs and nuclear factor-κB (NF-κB) in human disorders.
    Ghafouri-Fard S; Abak A; Fattahi F; Hussen BM; Bahroudi Z; Shoorei H; Taheri M
    Biomed Pharmacother; 2021 Jun; 138():111519. PubMed ID: 33756159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
    Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
    Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer.
    Gao C; Zhang Z; Liu W; Xiao S; Gu W; Lu H
    Cancer; 2010 Jan; 116(1):41-9. PubMed ID: 19890957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential microRNA therapies targeting Ras, NFkappaB and p53 signaling.
    Kasinski AL; Slack FJ
    Curr Opin Mol Ther; 2010 Apr; 12(2):147-57. PubMed ID: 20373258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway.
    Zhao L; Zhang Y
    Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.